Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BMB-101 by Bright Minds Biosciences for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy): Likelihood of Approval
BMB-101 is under clinical development by Bright Minds Biosciences and currently in Phase II for Dravet Syndrome (Severe Myoclonic Epilepsy...
BMB-101 by Bright Minds Biosciences for Absence Seizure: Likelihood of Approval
BMB-101 is under clinical development by Bright Minds Biosciences and currently in Phase II for Absence Seizure. According to GlobalData,...
BMB-101 by Bright Minds Biosciences for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy): Likelihood of Approval
BMB-101 is under clinical development by Bright Minds Biosciences and currently in Phase II for Dravet Syndrome (Severe Myoclonic Epilepsy...